GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pangen Biotech Inc (XKRX:222110) » Definitions » Purchase Of Business

Pangen Biotech (XKRX:222110) Purchase Of Business : ₩0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Pangen Biotech Purchase Of Business?

Pangen Biotech's purchase of business for the three months ended in Mar. 2024 was ₩0 Mil. It means Pangen Biotech spent ₩0 Mil on purchasing business. Pangen Biotech's purchase of business for the trailing twelve months (TTM) ended in Mar. 2024 was ₩0 Mil.

Compared with last quarter (₩0 Mil in Dec. 2023 ), Pangen Biotech spent the same money on purchasing business in Mar. 2024 (₩0 Mil).

Pangen Biotech Purchase Of Business Historical Data

The historical data trend for Pangen Biotech's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pangen Biotech Purchase Of Business Chart

Pangen Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pangen Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Pangen Biotech Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pangen Biotech Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Pangen Biotech's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Pangen Biotech (XKRX:222110) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pangen Biotech Inc (XKRX:222110) » Definitions » Purchase Of Business
Comparable Companies
XKRX:032790 XKRX:142760 XKRX:383930 XKRX:065650 XKRX:298060 XKRX:115180 XKRX:299660 XKRX:217730 XKRX:291650 XKRX:127120 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
4Floor Innoplex 2-dong, 306 Sinwon-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, KOR, 16675
Website
http://www.pangen.com
Pangen Biotech Inc is a biotechnology company. It is engaged in development of biosimilar products and technology transfer services for biologics development. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc.

Pangen Biotech (XKRX:222110) Headlines

No Headlines